Benitec Biopharma Ltd (BNTC)

[Blane]

Yeah, looking at the clinical trials dot gov website, the trial really has a robust list of criteria. But if they can cure someone with THOSE criteria, then it can be assumed they can cure anyone. Also, the author Pannobhaso on seeking alpha also stated that Gilead is finding out how difficult it is for anyone to truly afford their drugs, despite how effective. And with Olysio at a price of about 50k, the cost of a non-interferon treatment, non-RIBA treatment now rides at about 130k or so.

I say all that because Benitec's stock will go down a bit, but that's actually a good thing. For one, the drop is slightly predictable, which means people will be able to take advantage of cheaper stock. I actually sold some a while back, and am now waiting for it to dip below 1.52 or so. If it does, I will get more shares. This is just a dosing delay. It has nothing to do with the company's direction, abilities, or the technology. I hope those that start getting a little nervous will realize this. Sadly, there are a lot of emotional investors, rather than informational investors.

Blane